» Articles » PMID: 35689487

Adiposity-associated Atrial Fibrillation: Molecular Determinants, Mechanisms, and Clinical Significance

Overview
Journal Cardiovasc Res
Date 2022 Jun 11
PMID 35689487
Authors
Affiliations
Soon will be listed here.
Abstract

Obesity is an important contributing factor to the pathophysiology of atrial fibrillation (AF) and its complications by causing systemic changes, such as altered haemodynamic, increased sympathetic tone, and low-grade chronic inflammatory state. In addition, adipose tissue is a metabolically active organ that comprises various types of fat deposits with discrete composition and localization that show distinct functions. Fatty tissue differentially affects the evolution of AF, with highly secretory active visceral fat surrounding the heart generally having a more potent influence than the rather inert subcutaneous fat. A variety of proinflammatory, profibrotic, and vasoconstrictive mediators are secreted by adipose tissue, particularly originating from cardiac fat, that promote atrial remodelling and increase the susceptibility to AF. In this review, we address the role of obesity-related factors and in particular specific adipose tissue depots in driving AF risk. We discuss the distinct effects of key secreted adipokines from different adipose tissue depots and their participation in cardiac remodelling. The possible mechanistic basis and molecular determinants of adiposity-related AF are discussed, and finally, we highlight important gaps in current knowledge, areas requiring future investigation, and implications for clinical management.

Citing Articles

Translation of pathophysiological mechanisms of atrial fibrosis into new diagnostic and therapeutic approaches.

Schotten U, Goette A, Verheule S Nat Rev Cardiol. 2024; .

PMID: 39443702 DOI: 10.1038/s41569-024-01088-w.


Impact of overweight and obesity on radiation dose and outcome in patients undergoing pulmonary vein isolation by cryoballoon and pulsed field ablation.

Jungen C, Rattka M, Bohnen J, Mavrakis E, Vlachopoulou D, Dorna S Int J Cardiol Heart Vasc. 2024; 55:101516.

PMID: 39403597 PMC: 11471536. DOI: 10.1016/j.ijcha.2024.101516.


Potential Mechanisms of Epicardial Adipose Tissue Influencing Heart Failure with Preserved Ejection Fraction.

Li Q, Muhib U, Ma X, Liu Z, Gao F, Wang Z Rev Cardiovasc Med. 2024; 25(9):311.

PMID: 39355598 PMC: 11440401. DOI: 10.31083/j.rcm2509311.


Stellate ganglion, inflammation, and arrhythmias: a new perspective on neuroimmune regulation.

Lei Q, Jiang Z, Shao Y, Liu X, Li X Front Cardiovasc Med. 2024; 11:1453127.

PMID: 39328238 PMC: 11424448. DOI: 10.3389/fcvm.2024.1453127.


Thrombin receptor PAR4 cross-activates the tyrosine kinase c-met in atrial cardiomyocytes.

Mittendorff C, Abu-Taha I, Kassler L, Hustedt T, Wolf S, Bode J Naunyn Schmiedebergs Arch Pharmacol. 2024; .

PMID: 39283528 DOI: 10.1007/s00210-024-03436-6.


References
1.
Couselo-Seijas M, Lopez-Canoa J, Agra-Bermejo R, Diaz-Rodriguez E, Fernandez A, Martinez-Cereijo J . Cholinergic activity regulates the secretome of epicardial adipose tissue: Association with atrial fibrillation. J Cell Physiol. 2018; 234(7):10512-10522. DOI: 10.1002/jcp.27723. View

2.
Oliver M . Fatty acids and the risk of death during acute myocardial ischaemia. Clin Sci (Lond). 2014; 128(6):349-55. DOI: 10.1042/CS20140404. View

3.
Landstrom A, Dobrev D, Wehrens X . Calcium Signaling and Cardiac Arrhythmias. Circ Res. 2017; 120(12):1969-1993. PMC: 5607780. DOI: 10.1161/CIRCRESAHA.117.310083. View

4.
Katulska K, Milewska A, Wykretowicz M, Krauze T, Przymuszala D, Piskorski J . Arterial stiffness, body fat compartments, central hemodynamics, renal function and left atrial size. Scand J Clin Lab Invest. 2013; 73(7):563-8. DOI: 10.3109/00365513.2013.821711. View

5.
Chemaly E, Hadri L, Zhang S, Kim M, Kohlbrenner E, Sheng J . Long-term in vivo resistin overexpression induces myocardial dysfunction and remodeling in rats. J Mol Cell Cardiol. 2011; 51(2):144-55. PMC: 3124590. DOI: 10.1016/j.yjmcc.2011.04.006. View